Franklin Street Advisors Inc. NC Sells 67 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Franklin Street Advisors Inc. NC lowered its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 2.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,216 shares of the healthcare conglomerate’s stock after selling 67 shares during the period. Franklin Street Advisors Inc. NC’s holdings in UnitedHealth Group were worth $1,138,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in the company. Advocacy Wealth Management Services LLC increased its position in shares of UnitedHealth Group by 75.8% during the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 25 shares during the period. Cascade Investment Advisors Inc. increased its position in shares of UnitedHealth Group by 100.0% during the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 30 shares during the period. Rise Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $38,000. Evolution Advisers Inc. purchased a new position in shares of UnitedHealth Group during the first quarter worth approximately $38,000. Finally, Cordant Inc. purchased a new position in shares of UnitedHealth Group during the first quarter worth approximately $45,000. Institutional investors own 87.25% of the company’s stock.

UnitedHealth Group Trading Up 1.1 %

NYSE UNH opened at $517.46 on Friday. The company has a market capitalization of $484.02 billion, a PE ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. The company has a fifty day moving average of $530.11 and a 200 day moving average of $512.45. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The company had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. During the same quarter in the previous year, the company earned $4.70 earnings per share. The firm’s revenue for the quarter was up 12.6% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were issued a $1.65 dividend. The ex-dividend date was Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a yield of 1.28%. UnitedHealth Group’s payout ratio is 34.46%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on UNH shares. Mizuho raised their target price on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, August 10th. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. Loop Capital started coverage on shares of UnitedHealth Group in a report on Thursday, June 16th. They set a “buy” rating and a $575.00 price objective on the stock. SVB Leerink lifted their price objective on shares of UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a report on Monday, July 18th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a research note on Thursday, September 8th. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $586.40.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Stephen J. Hemsley sold 99,312 shares of the business’s stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the sale, the director now owns 787,372 shares of the company’s stock, valued at $420,669,238.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CFO John F. Rex sold 13,183 shares of the company’s stock in a transaction dated Friday, July 29th. The shares were sold at an average price of $541.53, for a total transaction of $7,138,989.99. Following the completion of the sale, the chief financial officer now owns 141,508 shares of the company’s stock, valued at approximately $76,630,827.24. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Stephen J. Hemsley sold 99,312 shares of the business’s stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the transaction, the director now owns 787,372 shares in the company, valued at $420,669,238.44. The disclosure for this sale can be found here. Over the last quarter, insiders sold 139,051 shares of company stock valued at $74,450,958. Corporate insiders own 0.40% of the company’s stock.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.